Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Advanced Diagnostics 2016

Lakshmi V Ramanathan's Biography



Lakshmi V Ramanathan, Chief, Clinical Chemistry Service, Memorial Sloan Kettering Cancer Center

Dr. Lakshmi V. Ramanathan received her PhD from the Massachusetts Institute of Technology in 1976 and is the Service Chief of the Clinical Chemistry Service, Associate Attending and Associate Clinical member in the Department of Laboratory Medicine at Memorial Sloan Kettering Cancer Center in New York City. Prior to joining Memorial Sloan Kettering Cancer Center, she was Director of Chemistry at Mount Sinai Medical Center in New York City.
Dr. Ramanathan is committed to improving patient care through education and research in the Chemistry section in the Department of Laboratory Medicine. She has trained numerous Clinical Pathology residents over a period of twenty five years and has developed a board certified fellowship program at Memorial Sloan Kettering Cancer Center in Clinical Chemistry. Her research interests include laboratory automation, point of care testing and the development of laboratory tests. She is a member of the Translational Medicine Research Group in Laboratory Medicine at Memorial Sloan Kettering Cancer Center and is currently collaborating with industry and several investigators to develop and improve clinical assays.
She is the current President of the New York Metro section of the American Association of Clinical Chemistry and has held leadership positions in the section since 2005. She has been recognized by AACC for her outstanding contributions to the section.

Lakshmi V Ramanathan Image

Latest Technologies for Disease Identification and Diagnosis

Thursday, 26 May 2016 at 09:00

Add to Calendar ▼2016-05-26 09:00:002016-05-26 10:00:00Europe/LondonLatest Technologies for Disease Identification and Diagnosis Advanced Diagnostics 2016 in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com

This Keynote Presentation will bring latest insights into the innovative technologies in disease identification. It will discuss the roadmap from Laboratory bench to bedside in the context of evidence based laboratory medicine. Further, it will discuss the impact & role of advances in technology and informatics in the standardization of methodologies (eg tumor marker standardization). Also, it will then mention studies involving interfering substances, limitations and reference ranges along with data interpretation which finally helps in the effective treatment of the patient.


Add to Calendar ▼2016-05-26 00:00:002016-05-27 00:00:00Europe/LondonAdvanced Diagnostics 2016Advanced Diagnostics 2016 in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com